Kyle Landgraf

Title: Innovations of Inventor Kyle Landgraf

Introduction

Kyle Landgraf is an accomplished inventor based in Alameda, CA. He holds a total of five patents, showcasing his contributions to the field of biotechnology and molecular engineering. His work primarily focuses on the development of modified NKG2D ligands and receptors, which have significant implications in therapeutic applications.

Latest Patents

One of Landgraf's latest patents involves the production of polypeptides comprised of modified α1-α2 domains of NKG2D ligands that bind specifically to a non-natural ectodomain of a non-natural NKG2D receptor. This innovation allows for the attachment of heterologous molecules to the modified α1-α2 domains, including polypeptides and antibodies. Another notable patent relates to insertable variable fragments of antibodies and modified α1-α2 domains of NKG2D ligands, emphasizing the specific antigen-binding properties of Fv domains.

Career Highlights

Throughout his career, Kyle Landgraf has worked with prominent companies in the biotechnology sector, including Xyphos Biosciences Inc. and Genentech, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field.

Collaborations

Landgraf has collaborated with notable professionals in his field, including Daniel P. Steiger and Tarah Baron, who have contributed to his research and development efforts.

Conclusion

Kyle Landgraf's innovative work in the field of biotechnology, particularly in the development of modified NKG2D ligands and receptors, highlights his significant contributions to science and technology. His patents reflect a commitment to advancing therapeutic applications and improving healthcare solutions.